Conexeu Sciences

Conexeu is a biotechnology and regenerative medicine company developing collagen-based extracellular matrix and hydrogel scaffold technologies for tissue repair and regeneration. Its operating model centers on development and commercialization of proprietary biomaterials used in wound healing, reconstructive procedures, medical aesthetics, and tissue engineering applications. The company’s CXU platform is designed to transition from liquid to gel at body temperature, forming a scaffold intended to support tissue integration and cellular regeneration. Conexeu is advancing applications across wound care, dermal fillers, reconstructive surgery, dental repair, veterinary medicine, and 3D bioprinting through internal development, clinical studies, and intellectual property licensing activities.